New therapy concept in the treatment of chronic tube ventilation disorders
Prof. Dr. med. Holger Sudhoff, FRCS (Lon), FRCPath Senior consultant of the Klinikum Bielefeld (Ear, nose and throat, head and neck surgery clinic, Bielefeld medical centre)“The use of microscopic and endoscopic technologies has revolutionised medicine and is state of the art today. With the development of balloon catheters, for example for the dilatation of heart coronaries, previously inconceivable revolutionary treatment concepts emerged. The transfer of this technology to the dilatation of the auditory tube provides the possibility for the first time to treat the cause of many chronic middle ear infections. Particularly for chronic tube dysfunctions or middle ear pathologies, there is now the opportunity to therapeutically approach the black box of otolaryngology. The new treatment concept provides the possibility for the first time to successfully treat chronic tube dysfunction and to provide our patients with a new treatment possibility for this previously untreatable condition.“ (Prof. Dr. Holger Sudhoff)
Obstructive tube dysfunction is a common chronic disorder in which the usual ventilation and the cleaning capability of the middle ear is restricted. Among other things, the consequences of this disorder is the development of chronic otitis media, that in the worst case can result in destruction of the middle ear (structures) and thus in hearing loss.
Prevalence of obstructive tube dysfunction is approximately 1% of the adult population1. TubaVent®, the first causative therapy concept for the treatment of any obstructive dysfunction of the tuba Eustachii (Eustachian tube) was developed in 2009.
1) Browning G, et al. The prevalence of middle ear disease in the adult British population. Clin Otolaryngol Allied Sci. 1992 Aug; 17(4):317-21